Trellis Bioscience Inc - Company Review
Trellis Bioscience Inc - Company ReviewSummary
Trellis Bioscience Inc (Trellis) is a healthcare services provider that offers therapies. The company discovers and develops human antibody therapeutics for the treatment of infectious diseases and cancer indications. It provides technology to defeat the deficiencies of current screening methods for antibodies. Trellis’ clinical candidate includes TRL1068 used for the treatment of infective endocarditis of the heart. The company develops CellSpot technology to find rare human antibodies. Its antibodies can be applied in the treatment of infectious disease such as respiratory syncytial virus, cytomegalovirus, auto-immune diseases, Influenza and cancer. The company provides pipeline of therapies in bacterial, viral, and cancer indications. It operates through government and philanthropic institutions, biotech and pharma companies. Trellis is headquartered in Menlo Park, California, the US.
This comprehensive company report of Trellis Bioscience Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.